Recently, a new model for how Park2 mutations and loss of mitophagy give rise to Parkinson's disease was proposed where in the absence of mitochondrial quality control, mitochondrial DNA is released from damaged mitochondria and acts as a pro‐inflammatory signal, driving local and systemic inflammation and subsequent neurodegeneration (Sliter et al., 2018). Here, PRKN is linked to Parkinson disease.